OH ANDREW M.
Insider CIK 1746614 · SYRS Director · RUBY Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise deriv | 2020-05-15 | 2020-05-19 | 5,000 | — | $0 | 755,500 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | M Exercise | 2020-05-15 | 2020-05-19 | 5,000 | $4.74 | $23.7K | 5,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2020-01-31 | 2020-02-03 | 165,000 | — | $0 | 165,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-01-31 | 2019-02-04 | 115,000 | — | $0 | 115,000 | SEC↗ |